SEARCH

SEARCH BY CITATION

References

  • Auerbach W. , Hurlbert M. S. , Hilditch-Maguire P. , Wadghiri Y. Z. , Wheeler V. C. , Cohen S. I. , Joyner A. L. , MacDonald M. E. and Turnbull D. H. (2001) The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. Hum. Mol. Genet. 10, 25152523.
  • Beal M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119130.
  • Beal M. F. , Kowall N. W. , Ellison D. W. , Mazurek M. F. , SwartZ. K. J. and Martin J. B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168171.
  • Cattaneo E. , Rigamonti D. , Goffredo D. , Zuccato C. , Squitieri F. and Sipione S. (2001) Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci. 24, 182188.
  • Cattaneo E. , Rigamonti D. and Zuccato C. (2002) The enigma of Huntington's disease. Sci. Am. 287, 9297.
  • Cepeda C. , Ariano M. A. , Calvert C. R. , Flores-Hernandez J. , Chandler S. H. , Leavitt B. R. , Hayden M. R. and Levine M. S. (2001) NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res. 66, 525539.
  • Cha J. H. (2000) Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23, 387392.
  • Chan E. Y. , Luthi-Carter R. , Strand A. et al. (2002) Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Hum. Mol. Genet. 11, 19391951.
  • Chen N. , Luo T. , Wellington C. , Metzler M. , McCutcheon K. , Hayden M. R. and Raymond L. A. (1999) Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J. Neurochem. 72, 18901898.
  • Coyle J. T. , Ferkany J. W. and Zaczek R. (1983) Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease. Neurobehav. Toxicol. Teratol. 5, 617624.
  • DiFiglia M. , Sapp E. , Chase K. O. , Davies S. W. , Bates G. P. , Vonsattel J. P. and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 19901993.
  • Dragatsis I. , Levine M. S. and Zeitlin S. (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet. 26, 300306.
  • Duyao M. P. , Auerbach A. B. , Ryan A. , Persichetti F. , Barnes G. T. , McNeil S. M. , Ge P. , Vonsattel J. P. , Gusella J. F. and Joyner A. L. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269, 407410.
  • Ellerby L. M. , Andrusiak R. L. , Wellington C. L. et al. (1999) Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. J. Biol. Chem. 274, 87308736.
  • Friedlander R. M. , Brown R. H. , Gagliardini V. , Wang J. and Yuan J. (1997) Inhibition of ICE slows ALS in mice. Nature 388, 31.
  • Fusco F. R. , Zuccato C. , Tartari M. , Martorana A. , De March Z. , Giampa C. , Cattaneo E. and Bernardi G. (2003) Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. Eur. J. Neurosci. 18, 10931102.
  • Gervais F. G. , Xu D. , Robertson G. S. et al. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97, 395406.
  • Goffredo D. , Rigamonti D. , Tartari M. , De Micheli A. , Verderio C. , Matteoli M. , Zuccato C. and Cattaneo E. (2002) Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J. Biol. Chem. 277, 39 59439 598.
  • Goldberg Y. P. , Nicholson D. W. , Rasper D. M. et al. (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract [see comments]. Nat. Genet. 13, 442449.
  • Hansson O. A. P. N. , Leist M. , Nicotera P. , Castilho R. F. and Brundin P. (1999) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl Acad. Sci. USA 96, 87278732.
  • Ho L. W. , Brown R. , Maxwell M. , Wyttenbach A. and Rubinsztein D. C. (2001) Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease. J. Med. Genet. 38, 450452.
  • Hodgson J. G. , Smith D. J. , McCutcheon K. et al. (1996) Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum. Mol. Genet. 5, 18751885.
  • Hodgson J. G. , Agopyan N. , Gutekunst C. A. et al. (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23, 181192.
  • Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group [see comments]. Cell 72, 971983.
  • Jana N. R. , Zemskov E. A. , Wang G. and Nukina N. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10, 10491059.
  • Leavitt B. R. , Guttman J. A. , Hodgson J. G. , Kimel G. H. , Singaraja R. , Vogl A. W. and Hayden M. R. (2001) Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am. J. Hum. Genet. 68, 313324.
  • Levine M. S. , Klapstein G. J. , Koppel A. et al. (1999) Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J. Neurosci. Res. 58, 515532.
  • Li S. H. , Lam S. , Cheng A. L. and Li X. J. (2000) Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis. Hum. Mol. Genet. 9, 28592867.
  • Luthi-Carter R. , Strand A. , Peters N. L. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Human Mol. Genet. 9, 12591271.
  • MacDonald M. E. and Gusella J. F. (1996) Huntington's disease: translating a CAG repeat into a pathogenic mechanism. Curr. Opin. Neurobiol. 6, 638643.
  • Martindale D. , Hackam A. , Wieczorek A. et al. (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat. Genet. 18, 150154.
  • McGeer E. G. and McGeer P. L. (1976) Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature 263, 517519.
  • Mende-Mueller L. M. , Toneff T. , Hwang S.-R. , Chesselet M.-F. and Hook V. Y. H. (2001) Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J. Neurosci. 21, 18301837.
  • Nasir J. , Floresco S. B. , O'Kusky J. R. , Diewert V. M. , Richman J. M. , Zeisler J. , Borowski A. , Marth J. D. , Phillips A. G. and Hayden M. R. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811823.
  • O'Kusky J. R. , Nasir J. , Cicchetti F. , Parent A. and Hayden M. R. (1999) Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene. Brain Res. 818, 468479.
  • Ona V. O. , Li M. , Vonsattel J. P. et al. (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease [see comments]. Nature 399, 263267.
  • Rigamonti D. , Bauer J. H. , De Fraja C. et al. (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci. 20, 37053713.
  • Rigamonti D. , Sipione S. , Goffredo D. , Zuccato C. , Fossale E. and Cattaneo E. (2001) Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing. J. Biol. Chem. 276, 14 54514 548.
  • Sanchez I. , Xu C. J. , Juo P. , Kakizaka A. , Blenis J. and Yuan J. (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats [see comments]. Neuron 22, 623633.
  • Sharp A. H. , Loev S. J. , Schilling G. , Li S. H. , Li X. J. , Bao J. , Wagster M. V. , Kotzuk J. A. , Steiner J. P. and Lo A. (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 10651074.
  • Sugars K. L. and Rubinsztein D. C. (2003) Transcriptional abnormalities in Huntington disease. Trends Genet. 19, 233238.
  • Wellington C. L. and Hayden M. R. (1997) Of molecular interactions, mice and mechanisms: new insights into Huntington's disease. Curr. Opin. Neurol. 10, 291298.
  • Wellington C. L. , Ellerby L. M. , Hackam A. S. et al. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 91589167.
  • Wellington C. L. , Singaraja R. , Ellerby L. et al. (2000) Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275, 19 83119 838.
  • Wellington C. L. , Ellerby L. M. , Gutekunst C. A. et al. (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22, 78627872.
  • Wyttenbach A. , Carmichael J. , Swartz J. , Furlong R. A. , Narain Y. , Rankin J. and Rubinsztein D. C. (2000) Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc. Natl Acad. Sci. USA 97, 28982903.
  • Zeitlin S. , Liu J. P. , Chapman D. L. , Papaioannou V. E. and Efstratiadis A. (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11, 155163.
  • Zeron M. M. , Chen N. , Moshaver A. , Lee A. T. , Wellington C. L. , Hayden M. R. and Raymond L. A. (2001) Mutant huntingtin enhances excitotoxic cell death. Mol. Cell. Neurosci. 17, 4153.
  • Zeron M. M. , Hansson O. , Chen N. , Wellington C. L. , Leavitt B. R. , Brundin P. , Hayden M. R. and Raymond L. A. (2002) Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 14, 849860.